Cargando…

Adenosine A(2A) Receptor Occupancy by Long‐Term Istradefylline Administration in Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Ishibashi, Kenji, Miura, Yoshiharu, Wagatsuma, Kei, Toyohara, Jun, Ishiwata, Kiichi, Ishii, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894182/ https://www.ncbi.nlm.nih.gov/pubmed/33200448 http://dx.doi.org/10.1002/mds.28378

Ejemplares similares

Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2022)

Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using (11)C-ITMM positron emission tomography
por: Ishibashi, Kenji, et al.
Publicado: (2019)

Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [(11)C]CB184, in healthy human volunteers
por: Sakata, Muneyuki, et al.
Publicado: (2017)

A Pooled Analysis From Phase 2b and 3 Studies in Japan of Istradefylline in Parkinson's Disease
por: Hattori, Nobutaka, et al.
Publicado: (2020)

Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson’s disease and multiple system atrophy: a case report
por: Ishibashi, Kenji, et al.
Publicado: (2015)

Age-Related Decrease in Male Extra-Striatal Adenosine A(1) Receptors Measured Using (11)C-MPDX PET
por: Mishina, Masahiro, et al.
Publicado: (2017)

Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using (18)F-THK5351 positron emission tomography
por: Ishibashi, Kenji, et al.
Publicado: (2020)

Adenosine A(2A) receptor antagonist istradefylline reduces daily OFF time in Parkinson’s disease
por: Mizuno, Yoshikuni, et al.
Publicado: (2013)

Adenosine A(2A) Receptors Measured with [(11)C]TMSX PET in the Striata of Parkinson's Disease Patients
por: Mishina, Masahiro, et al.
Publicado: (2011)

Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease
por: Nuermaimaiti, Maierdanjiang, et al.
Publicado: (2018)

The effect of istradefylline for Parkinson’s disease: A meta-analysis
por: Sako, Wataru, et al.
Publicado: (2017)

Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human Subjects
por: Ishikawa, Masatomo, et al.
Publicado: (2011)

Binding of Pramipexole to Extrastriatal Dopamine D(2)/D(3) Receptors in the Human Brain: A Positron Emission Tomography Study Using (11)C-FLB 457
por: Ishibashi, Kenji, et al.
Publicado: (2011)

Effects of glucose, insulin, and insulin resistance on cerebral (18)F-FDG distribution in cognitively normal older subjects
por: Ishibashi, Kenji, et al.
Publicado: (2017)

Istradefylline Improves Impaired Smooth Pursuit Eye Movements in Parkinson’s Disease
por: Fujita, Youshi, et al.
Publicado: (2023)

PET Imaging of (18)F-FDG, (11)C-methionine, (11)C-flumazenil, and (11)C-4DST in Progressive Multifocal Leukoencephalopathy
por: Ishibashi, Kenji, et al.
Publicado: (2017)

Changes in cerebral blood flow during steady-state cycling exercise: a study using oxygen-15-labeled water with PET
por: Hiura, Mikio, et al.
Publicado: (2014)

Test-retest variability of adenosine A(2A) binding in the human brain with (11)C-TMSX and PET
por: Naganawa, Mika, et al.
Publicado: (2014)

Longitudinal effects of aging on (18)F-FDG distribution in cognitively normal elderly individuals
por: Ishibashi, Kenji, et al.
Publicado: (2018)

In Vivo Evaluation of (11)C-labeled Three Radioligands for Glycine Transporter 1 in the Mouse Brain
por: Zhang, Ji-chun, et al.
Publicado: (2012)

Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “Off” Episodes: A Comprehensive Review
por: Berger, Amnon A., et al.
Publicado: (2020)

Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
por: Isaacson, Stuart H, et al.
Publicado: (2022)

Separation and identification of an impurity from the istradefylline intermediate
por: Xu, Haojie, et al.
Publicado: (2020)

Possibility of Enlargement in Left Medial Temporal Areas Against Cerebral Amyloid Deposition Observed During Preclinical Stage
por: Imabayashi, Etsuko, et al.
Publicado: (2022)

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
por: Pagan, Fernando L., et al.
Publicado: (2020)

Metabolic Network Topology of Alzheimer’s Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography
por: Imai, Masamichi, et al.
Publicado: (2020)

Voxel-based morphometry focusing on medial temporal lobe structures has a limited capability to detect amyloid β, an Alzheimer’s disease pathology
por: Kameyama, Masashi, et al.
Publicado: (2020)

Istradefylline Versus Opicapone for “Off” Episodes in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Singh, Alok, et al.
Publicado: (2021)

Efficacy of Istradefylline, an Adenosine A(2A) Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
por: Hauser, Robert A., et al.
Publicado: (2021)

Reversible istradefylline-induced pleurothotonus in a patient with Parkinson's disease: A case report and literature review
por: Yasuda, Yuzuru
Publicado: (2018)

Istradefylline: A novel agent in the treatment of “off” episodes associated with levodopa/carbidopa use in Parkinson disease
por: Cummins, Lauren, et al.
Publicado: (2022)

Focal Subthalamic Atrophy after Long‐Term Deep Brain Stimulation in Parkinson's Disease
por: Gelpi, Ellen, et al.
Publicado: (2021)

In Vivo Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists [(11)C]A-582941 and [(11)C]A-844606 in Mice and Conscious Monkeys
por: Toyohara, Jun, et al.
Publicado: (2010)

No entry for adenosine
por: Van Epps, Heather L.
Publicado: (2005)

Direct comparison of brain [(18)F]FDG images acquired by SiPM-based and PMT-based PET/CT: phantom and clinical studies
por: Wagatsuma, Kei, et al.
Publicado: (2020)

Effects of Rifampin on the Pharmacokinetics of a Single Dose of Istradefylline in Healthy Subjects
por: Mukai, Mayumi, et al.
Publicado: (2017)

Istradefylline effects on tremor dominance (TD) and postural instability and gait difficulty (PIGD)
por: Torres-Yaghi, Yasar, et al.
Publicado: (2023)

Reliable radiosynthesis of 4-[(10)B]borono-2-[(18)F]fluoro-l-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis
por: Ishiwata, Kiichi, et al.
Publicado: (2018)

Effects of exercise on brain activity during walking in older adults: a randomized controlled trial
por: Shimada, Hiroyuki, et al.
Publicado: (2017)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d2ufgetamimt2pmhai8k9pm7po